| 摘要 |
<p>The present invention relates to the use of diacylglycerol kinase delta (DGK δ) in methods for the identification of pharmaceutically useful agents, in particular agents useful for increasing insulin-stimulated glucose uptake in a mammalian cell and for the treatment or prophylaxis of diabetes.</p> |
